Screening of differentially expressed genes related to esophageal squamous cell carcinoma and functional analysis with DNA microarrays

International Journal of Oncology

Volumn 44, Issue 4, 2014, Pages 1163-1170

  Yuan, Yunfeng ^a   Xue, Liang ^a   Fan, Hong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Differentially expressed gene; Esophageal squamous cell carcinoma; Function and pathway analysis; Hub gene; Interaction network

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CATHEPSIN K; CTSK PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 8; TSPO PROTEIN, HUMAN;

BIOLOGY; DNA MICROARRAY; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; HUMAN; NUCLEIC ACID DATABASE; PROCEDURES; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CATHEPSIN K; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; INTERLEUKIN-8; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPS; RECEPTORS, GABA; SIGNAL TRANSDUCTION;

EID: 84894473092     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2262     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Lin Y, Totsuka Y, He Y, et al: Epidemiology of esophageal cancer in Japan and China. J Epidemiol 23: 233-242, 2013.
3. Toh Y, Oki E, Ohgaki K, et al: Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol 15: 135-144, 2010.
4. Motoyama S, Jin M, Matsuhashi T, et al: Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal, but pathologically submucosal, squamous cell carcinoma of the esophagus. Surg Today 43: 638-642, 2013.
5. Urabe Y, Hiyama T, Tanaka S, Yoshihara M, Arihiro K and Chayama K: Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol 26: 275-280, 2011.
6. Isomoto H, Yamaguchi N, Nakayama T, et al: Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol 11: 46, 2011.
7. Umar SB and Fleischer DE: Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5: 517-526, 2008.
8. Wong GS: Periostin and its role in promoting invasion in the tumor microenvironment of esophageal cancer. ProQuest. Paper AAI3551813.
9. Bhatnagar J, Heroman W, Murphy M and Austin GE: Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms. Anticancer Res 22: 1849-1857, 2002.
10. Cheung L, Lai K, Lam A, et al: Gene expression profiling identified high-mobility group AT-hook 2 (HMGA2) as being frequently upregulated in esophageal squamous cell carcinoma. Br J Med Med Res 3: 407-419, 2013.
11. Spies M, Dasu MR, Svrakic N, et al: Gene expression analysis in burn wounds of rats. Am J Physiol Regul Integr Comp Physiol 283: R918-R930, 2002.
12. Hu N, Clifford R, Yang H, et al: Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics 11: 576, 2010.
13. Marques FZ, Campain AE, Tomaszewski M, et al: Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 58: 1093-1098, 2011.
14. Fujita A, Sato J, Rodrigues L, Ferreira C and Sogayar M: Evaluating different methods of microarray data normalization. BMC Bioinformatics 7: 469, 2006.
15. Smyth GK: Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry R and Huber W (eds.) Springer, New York, pp397-420, 2005.
16. Benjamini Y and Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol pp289-300, 1995.
17. Szklarczyk D, Franceschini A, Kuhn M, et al: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-D568, 2011.
18. Albert R: Scale-free networks in cell biology. J Cell Sci 118: 4947-4957, 2005.
19. Bruckner S, Hüffner F, Karp RM, Shamir R and Sharan R: Topology-free querying of protein interaction networks. J Comput Biol 17: 237-252, 2010.
20. Wu X-R, Zhu Y and Li Y: Analyzing protein interaction networks via random graph model. Int J Inform Technol 11: 125-132, 2005.
21. Miller GA, Shi YY, Qian H and Bomsztyk K: Clustering coefficients of protein-protein interaction networks. Phys Rev E 75: 051910, 2007.
22. Xu K, Bezakova I, Bunimovich L and Yi SV: Path lengths in protein-protein interaction networks and biological complexity. Proteomics 11: 1857-1867, 2011.
23. Willis RC and Hogue CW: Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Curr Protoc Bioinformatics 8.9. 1-8.9. 30, 2006.
24. Breitkreutz B-J, Stark C and Tyers M: The GRID: the general repository for interaction datasets. Genome Biol 4: R23, 2003.
25. Breitkreutz B-J, Stark C and Tyers M: Osprey: a network visualization system. Genome Biol 4: R22, 2003.
26. Nam D and Kim SY: Gene-set approach for expression pattern analysis. Brief Bioinform 9: 189-197, 2008.
27. Allison DB, Cui X, Page GP and Sabripour M: Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7: 55-65, 2006.
28. Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2008.
29. Huang da W, Sherman BT and Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13, 2009.
30. Scarf AM, Ittner LM and Kassiou M: The translocator protein (18 kDa): central nervous system disease and drug design. J Med Chem 52: 581-592, 2009.
31. Papadopoulos V, Baraldi M, Guilarte TR, et al: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27: 402-409, 2006.
32. Veenman L, Alten J, Linnemannstöns K, et al: Potential involvement of F0F1-ATP (synth) ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines. Apoptosis 15: 753-768, 2010.
33. Veenman L and Gavish M: The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr Mol Med 12: 398-412, 2012.
34. Veenman L, Shandalov Y and Gavish M: VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J Bioenerg Biomembr 40: 199-205, 2008.
35. Zeno S, Zaaroor M, Leschiner S, Veenman L and Gavish M: CoCl2 induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 48: 4652-4661, 2009.
36. Veenman L, Weizman A, Weisinger G and Gavish M: Expression and functions of the 18 kDa mitochondrial translocator protein (TSPO) in health and disease. Target Drug Deliv Cancer Ther 2010.
37. Veenman L, Papadopoulos V and Gavish M: Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 13: 2385-2405, 2007.
38. Medzhitov R, Preston-Hurlburt P and Janeway CA: A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 388: 394-397, 1997.
39. Takeda K, Kaisho T and Akira S: Toll-like receptors. Annu Rev Immunol 21: 335-376, 2003.
40. Hennessy EJ, Parker AE and O'Neill LA: Targeting toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9: 293-307, 2010.
41. Lim DM and Wang ML: Toll-like receptor 3 signaling enables human esophageal epithelial cells to sense endogenous danger signals released by necrotic cells. Am J Physiol Gastrointest Liver Physiol 301: G91-G99, 2011.
42. Ho N, Punturieri A, Wilkin D, et al: Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein. J Bone Miner Res 14: 1649-1653, 1999.
43. Asagiri M, Hirai T, Kunigami T, et al: Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319: 624-627, 2008.
44. Hirai T, Kanda T, Sato K, et al: Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation. J Immunol 190: 4805-4811, 2013.
45. Todorović-Raković N and Milovanović J: Interleukin-8 in breast cancer progression. J Interferon Cytokine Res 33: 563-570, 2013.
46. Lim DM, Narasimhan S, Michaylira CZ and Wang ML: TLR3-mediated NF-κB signaling in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol 297: G1172-G1180, 2009.
47. Sun Y, Ishibashi M, Seimon T, et al: Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ Res 104: 455-465, 2009.
48. Xie L, Moroi Y, Hayashida S, et al: Cathepsin K-upregulation in fibroblasts promotes matrigel invasive ability of squamous cell carcinoma cells via tumor-derived IL-1α. J Dermatol Sci 61: 45-50, 2011.